Research ArticleNuclear Oncology
Tumor Metabolic Rates in Sarcoma Using FDG PET
Janet F. Eary and David A. Mankoff
Journal of Nuclear Medicine February 1998, 39 (2) 250-254;
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Journal of Nuclear Medicine
Vol. 39, Issue 2
February 1, 1998
Tumor Metabolic Rates in Sarcoma Using FDG PET
Janet F. Eary, David A. Mankoff
Journal of Nuclear Medicine Feb 1998, 39 (2) 250-254;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Assessing the Effect of Various Blood Glucose Levels on 18F-FDG Activity in the Brain, Liver, and Blood Pool
- PET Tumor Metabolism in Locally Advanced Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: Value of Static versus Kinetic Measures of Fluorodeoxyglucose Uptake
- Standards for PET Image Acquisition and Quantitative Data Analysis
- Spatial Heterogeneity in Sarcoma 18F-FDG Uptake as a Predictor of Patient Outcome
- SUV Varies with Time After Injection in 18F-FDG PET of Breast Cancer: Characterization and Method to Adjust for Time Differences
- Soft Tissue Sarcomas of Adults: State of the Translational Science
- PET Imaging of Osteosarcoma
- Lung Cancer Proliferation Correlates with [F-18]Fluorodeoxyglucose Uptake by Positron Emission Tomography
- (F-18) Fluorodeoxyglucose Positron Emission Tomography as a Predictor of Pathologic Grade and Other Prognostic Variables in Bone and Soft Tissue Sarcoma
- Evaluation of 18fluorodeoxyglucose positron emission tomography (18FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1